Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 25, 2021Annals of the Rheumatic DiseasesOpen Access

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RHRebecca H. HabermanNew York UniversityRHRamin S. HeratiNYU Langone HealthDSDavid SimónNortheastern University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Haberman et al. (2021) studied this question.

synapsesocial.com/papers/6a7ec0e9ec6d7e203fcda5b7https://doi.org/10.1136/annrheumdis-2021-220597
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor2011 · 95 citations
  2. 2An mRNA Vaccine against SARS-CoV-2 — Preliminary Report2020 · 3,520 citations
  3. 3Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial2018 · 220 citations